52 Followers on Owler
IMUNON is a New Jersey-based biotechnology company that researches and develops non-viral DNA-mediated immunotherapies for the treatment of cancer and infectious diseases... Read more
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights
IMUNON is a New Jersey-based biotechnology company that researches and develops non-viral DNA-mediated immunotherapies for the treatment of cancer and infectious diseases... Read more
Imunon President & CEO: Stacy R. Lindborg

President & CEO

Stacy R. Lindborg

CEO Approval Rating

90/100

1982

PublicNASDAQIMNN

Pharmaceuticals & Biotechnology
Biotechnology

Annual Revenue
<$1M
Employees
30
Funding
$198.3M
Acquisitions
1
Investments
1

News

Funding
May 29, 2025
GlobeNewswire
Imunon received $3.3M in Private Placement Funding

Imunon Competitors

1Dynavax
2Iovance
3Hookipa Pharma
4bluebird bio
5Onconova Therapeutics
6Kite Pharma
7Sangamo
8Silverback Therapeutics
9Lpath
10CTI BioPharma
Unlock 13 + competitors